Amicus Therapeutics (FOLD) Free Cash Flow by Year
Amicus Therapeutics, Inc generated $29.8M in free cash flow in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Amicus Therapeutics, Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
FOLD Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
FOLD Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Amicus Therapeutics, Inc financials
Frequently Asked Questions
Amicus Therapeutics, Inc generated $29.8M in free cash flow in fiscal year 2025.
Amicus Therapeutics, Inc (FOLD) reported an outflow of $37.4M in free cash flow in fiscal year 2024 and $29.8M in free cash flow in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Across the 15 fiscal years this page covers, Amicus Therapeutics, Inc (FOLD) free cash flow went from -$50.8M in fiscal year 2011 to $29.8M in fiscal year 2025.
Amicus Therapeutics, Inc (FOLD) reported $16.0M in free cash flow in Q4 2025. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Amicus Therapeutics, Inc (FOLD) reported on that line in every period on record.